NCT06681220 2026-03-11Relapsed SCLCVA Office of Research and DevelopmentPhase 1/2 Recruiting166 enrolled
NCT03878849 2025-08-28Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian CancerAllarity TherapeuticsPhase 2 Recruiting40 enrolled